Faster access than browser!Similarities between Alzheimer's disease and Mild cognitive impairment
Alzheimer's disease and Mild cognitive impairment have 28 things in common (in Unionpedia): Acetylcholinesterase inhibitor, Activities of daily living, Adverse drug reaction, Aging brain, Alzheimer's Association, Amino acid, Amyloid, Amyloid beta, Blood test, Cognitive deficit, Cognitive training, Dementia, Donepezil, Folate, Food and Drug Administration, Frontal lobe, Longitudinal study, Magnetic resonance imaging, Neurofibrillary tangle, Neuropsychological test, Pathogenesis, Pittsburgh compound B, Positron emission tomography, Prevalence, Prodrome, Rivastigmine, Temporal lobe, Vitamin B12.
Acetylcholinesterase inhibitor
An acetylcholinesterase inhibitor (often abbreviated AChEI) or anti-cholinesterase is a chemical or a drug that inhibits the acetylcholinesterase enzyme from breaking down acetylcholine, thereby increasing both the level and duration of action of the neurotransmitter acetylcholine.
Acetylcholinesterase inhibitor and Alzheimer's disease · Acetylcholinesterase inhibitor and Mild cognitive impairment ·
Activities of daily living
Activities of daily living (ADLs or ADL) is a term used in healthcare to refer to people's daily self care activities.
Activities of daily living and Alzheimer's disease · Activities of daily living and Mild cognitive impairment ·
Adverse drug reaction
An adverse drug reaction (ADR) is an injury caused by taking a medication.
Adverse drug reaction and Alzheimer's disease · Adverse drug reaction and Mild cognitive impairment ·
Aging brain
Aging is a major risk factor for most common neurodegenerative diseases, including mild cognitive impairment, dementias including Alzheimer's disease, cerebrovascular disease, Parkinson's disease and Lou Gehrig's disease.
Aging brain and Alzheimer's disease · Aging brain and Mild cognitive impairment ·
Alzheimer's Association
The Alzheimer's Association was founded by Jerome H. Stone with the help of several family members in Chicago, Illinois and incorporated in April 10, 1980 as the Alzheimer's Disease and Related Disorders Association, Inc. and is a non-profit American volunteer health organization which focuses on care, support and research for Alzheimer's disease.
Alzheimer's Association and Alzheimer's disease · Alzheimer's Association and Mild cognitive impairment ·
Amino acid
Amino acids are organic compounds containing amine (-NH2) and carboxyl (-COOH) functional groups, along with a side chain (R group) specific to each amino acid.
Alzheimer's disease and Amino acid · Amino acid and Mild cognitive impairment ·
Amyloid
Amyloids are aggregates of proteins that become folded into a shape that allows many copies of that protein to stick together forming fibrils.
Alzheimer's disease and Amyloid · Amyloid and Mild cognitive impairment ·
Amyloid beta
Amyloid beta (Aβ or Abeta) denotes peptides of 36–43 amino acids that are crucially involved in Alzheimer's disease as the main component of the amyloid plaques found in the brains of Alzheimer patients.
Alzheimer's disease and Amyloid beta · Amyloid beta and Mild cognitive impairment ·
Blood test
A blood test is a laboratory analysis performed on a blood sample that is usually extracted from a vein in the arm using a hypodermic needle, or via fingerprick.
Alzheimer's disease and Blood test · Blood test and Mild cognitive impairment ·
Cognitive deficit
Cognitive deficit or cognitive impairment is an inclusive term to describe any characteristic that acts as a barrier to the cognition process.
Alzheimer's disease and Cognitive deficit · Cognitive deficit and Mild cognitive impairment ·
Cognitive training
The term cognitive training (also called brain training or neurobics) reflects a hypothesis that cognitive abilities can be maintained or improved by exercising the brain, in an analogy to the way physical fitness is improved by exercising the body.
Alzheimer's disease and Cognitive training · Cognitive training and Mild cognitive impairment ·
Dementia
Dementia is a broad category of brain diseases that cause a long-term and often gradual decrease in the ability to think and remember that is great enough to affect a person's daily functioning.
Alzheimer's disease and Dementia · Dementia and Mild cognitive impairment ·
Donepezil
Donepezil, marketed under the trade name Aricept, is a medication used in the palliative treatment of Alzheimer's disease.
Alzheimer's disease and Donepezil · Donepezil and Mild cognitive impairment ·
Folate
Folate, distinct forms of which are known as folic acid, folacin, and vitamin B9, is one of the B vitamins.
Alzheimer's disease and Folate · Folate and Mild cognitive impairment ·
Food and Drug Administration
The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments.
Alzheimer's disease and Food and Drug Administration · Food and Drug Administration and Mild cognitive impairment ·
Frontal lobe
The frontal lobe, located at the front of the brain, is the largest of the four major lobes of the cerebral cortex in the mammalian brain.
Alzheimer's disease and Frontal lobe · Frontal lobe and Mild cognitive impairment ·
Longitudinal study
A longitudinal study (or longitudinal survey, or panel study) is a research design that involves repeated observations of the same variables (e.g., people) over short or long periods of time (i.e., uses longitudinal data).
Alzheimer's disease and Longitudinal study · Longitudinal study and Mild cognitive impairment ·
Magnetic resonance imaging
Magnetic resonance imaging (MRI) is a medical imaging technique used in radiology to form pictures of the anatomy and the physiological processes of the body in both health and disease.
Alzheimer's disease and Magnetic resonance imaging · Magnetic resonance imaging and Mild cognitive impairment ·
Neurofibrillary tangle
Neurofibrillary tangles (NFTs) are aggregates of hyperphosphorylated tau protein that are most commonly known as a primary marker of Alzheimer's disease.
Alzheimer's disease and Neurofibrillary tangle · Mild cognitive impairment and Neurofibrillary tangle ·
Neuropsychological test
Neuropsychological tests are specifically designed tasks used to measure a psychological function known to be linked to a particular brain structure or pathway.
Alzheimer's disease and Neuropsychological test · Mild cognitive impairment and Neuropsychological test ·
Pathogenesis
The pathogenesis of a disease is the biological mechanism (or mechanisms) that leads to the diseased state.
Alzheimer's disease and Pathogenesis · Mild cognitive impairment and Pathogenesis ·
Pittsburgh compound B
Pittsburgh compound B (PiB) is a radioactive analog of thioflavin T, which can be used in positron emission tomography scans to image beta-amyloid plaques in neuronal tissue.
Alzheimer's disease and Pittsburgh compound B · Mild cognitive impairment and Pittsburgh compound B ·
Positron emission tomography
Positron-emission tomography (PET) is a nuclear medicine functional imaging technique that is used to observe metabolic processes in the body as an aid to the diagnosis of disease.
Alzheimer's disease and Positron emission tomography · Mild cognitive impairment and Positron emission tomography ·
Prevalence
Prevalence in epidemiology is the proportion of a particular population found to be affected by a medical condition (typically a disease or a risk factor such as smoking or seat-belt use).
Alzheimer's disease and Prevalence · Mild cognitive impairment and Prevalence ·
Prodrome
In medicine, a prodrome is an early sign or symptom (or set of signs and symptoms), which often indicate the onset of a disease before more diagnostically specific signs and symptoms develop.
Alzheimer's disease and Prodrome · Mild cognitive impairment and Prodrome ·
Rivastigmine
Rivastigmine (sold under the trade name Exelon) is a acetylcholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease and Parkinson's.
Alzheimer's disease and Rivastigmine · Mild cognitive impairment and Rivastigmine ·
Temporal lobe
The temporal lobe is one of the four major lobes of the cerebral cortex in the brain of mammals.
Alzheimer's disease and Temporal lobe · Mild cognitive impairment and Temporal lobe ·
Vitamin B12
Vitamin B12, also called cobalamin, is a water-soluble vitamin that is involved in the metabolism of every cell of the human body: it is a cofactor in DNA synthesis, and in both fatty acid and amino acid metabolism.
Alzheimer's disease and Vitamin B12 · Mild cognitive impairment and Vitamin B12 ·
The list above answers the following questions
- What Alzheimer's disease and Mild cognitive impairment have in common
- What are the similarities between Alzheimer's disease and Mild cognitive impairment
Alzheimer's disease and Mild cognitive impairment Comparison
Alzheimer's disease has 410 relations, while Mild cognitive impairment has 52. As they have in common 28, the Jaccard index is 6.06% = 28 / (410 + 52).
References
This article shows the relationship between Alzheimer's disease and Mild cognitive impairment. To access each article from which the information was extracted, please visit:
